1. Home
  2. KALA vs MNY Comparison

KALA vs MNY Comparison

Compare KALA & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • MNY
  • Stock Information
  • Founded
  • KALA 2009
  • MNY 2014
  • Country
  • KALA United States
  • MNY Singapore
  • Employees
  • KALA N/A
  • MNY N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • KALA Health Care
  • MNY
  • Exchange
  • KALA Nasdaq
  • MNY Nasdaq
  • Market Cap
  • KALA 26.2M
  • MNY 31.9M
  • IPO Year
  • KALA 2017
  • MNY N/A
  • Fundamental
  • Price
  • KALA $5.16
  • MNY $1.02
  • Analyst Decision
  • KALA Strong Buy
  • MNY Strong Buy
  • Analyst Count
  • KALA 3
  • MNY 1
  • Target Price
  • KALA $14.00
  • MNY $4.00
  • AVG Volume (30 Days)
  • KALA 71.9K
  • MNY 257.8K
  • Earning Date
  • KALA 08-05-2025
  • MNY 06-13-2025
  • Dividend Yield
  • KALA N/A
  • MNY N/A
  • EPS Growth
  • KALA N/A
  • MNY N/A
  • EPS
  • KALA N/A
  • MNY N/A
  • Revenue
  • KALA N/A
  • MNY $71,649,746.00
  • Revenue This Year
  • KALA N/A
  • MNY $31.98
  • Revenue Next Year
  • KALA N/A
  • MNY $10.97
  • P/E Ratio
  • KALA N/A
  • MNY N/A
  • Revenue Growth
  • KALA N/A
  • MNY N/A
  • 52 Week Low
  • KALA $2.92
  • MNY $0.55
  • 52 Week High
  • KALA $11.20
  • MNY $1.88
  • Technical
  • Relative Strength Index (RSI)
  • KALA 61.92
  • MNY 69.38
  • Support Level
  • KALA $4.36
  • MNY $0.66
  • Resistance Level
  • KALA $5.75
  • MNY $1.10
  • Average True Range (ATR)
  • KALA 0.53
  • MNY 0.09
  • MACD
  • KALA 0.07
  • MNY 0.03
  • Stochastic Oscillator
  • KALA 64.39
  • MNY 81.82

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

Share on Social Networks: